Search research articles
Contact Us
Filters
Showing results (141-150 of 290) with videos related to
Page
of 29
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 16, 2024
Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter Study
An Outtier, Edouard Louis, Olivier Dewit, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 21, 2013
FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity
Babak Saboury, Ali Salavati, Alex Brothers, et al.
Alimentary Pharmacology & Therapeutics
|
October 21, 2022
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials
Laurent Peyrin-Biroulet, Subrata Ghosh, Scott D Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 15, 2025
Impact of Extended Risankizumab Treatment in Patients With Ulcerative Colitis Who Did Not Respond to Induction Treatment
Remo Panaccione, Gil Y Melmed, David Drobne, et al.
Crohn'S & Colitis 360
|
March 20, 2023
The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease
Jamie M Horrigan, Edouard Louis, Antonino Spinelli, et al.
Aging Clinical and Experimental Research
|
April 4, 2026
Effects of prehabilitation programmes on postoperative outcomes in older adults undergoing major abdominal, cardiac or vascular surgery: a systematic review
Fanny Buckinx, Anne-Françoise Rousseau, Edouard Louis, et al.
Clinical Chemistry
|
April 26, 2008
Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis
Dominique de Seny, Marianne Fillet, Clio Ribbens, et al.
United European Gastroenterology Journal
|
October 25, 2024
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study
Stefan Schreiber, Brian G Feagan, Edouard Louis, et al.
Gastroenterology
|
January 10, 2002
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up
Filip Baert, Alain Schmit, Geert D'Haens, et al.
Pharmacogenetics and Genomics
|
December 14, 2005
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease
Stéphanie Willot, Severine Vermeire, Marc Ohresser, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 290) with videos related to
Sort By:
Page
of 29
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 16, 2024
Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter Study
An Outtier, Edouard Louis, Olivier Dewit, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 21, 2013
FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity
Babak Saboury, Ali Salavati, Alex Brothers, et al.
Alimentary Pharmacology & Therapeutics
|
October 21, 2022
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials
Laurent Peyrin-Biroulet, Subrata Ghosh, Scott D Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 15, 2025
Impact of Extended Risankizumab Treatment in Patients With Ulcerative Colitis Who Did Not Respond to Induction Treatment
Remo Panaccione, Gil Y Melmed, David Drobne, et al.
Crohn'S & Colitis 360
|
March 20, 2023
The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease
Jamie M Horrigan, Edouard Louis, Antonino Spinelli, et al.
Aging Clinical and Experimental Research
|
April 4, 2026
Effects of prehabilitation programmes on postoperative outcomes in older adults undergoing major abdominal, cardiac or vascular surgery: a systematic review
Fanny Buckinx, Anne-Françoise Rousseau, Edouard Louis, et al.
Clinical Chemistry
|
April 26, 2008
Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis
Dominique de Seny, Marianne Fillet, Clio Ribbens, et al.
United European Gastroenterology Journal
|
October 25, 2024
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study
Stefan Schreiber, Brian G Feagan, Edouard Louis, et al.
Gastroenterology
|
January 10, 2002
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up
Filip Baert, Alain Schmit, Geert D'Haens, et al.
Pharmacogenetics and Genomics
|
December 14, 2005
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease
Stéphanie Willot, Severine Vermeire, Marc Ohresser, et al.
Page
of 29